| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 7.967 | 11.990 | 17.335 | 22.684 | 43.693 | 29.762 | 8.442 | 22.444 | 22.935 |
| Total Income - EUR | - | 7.971 | 12.000 | 18.181 | 27.090 | 44.467 | 30.922 | 8.446 | 46.179 | 22.985 |
| Total Expenses - EUR | - | 1.440 | 6.580 | 6.009 | 7.356 | 18.264 | 17.547 | 14.520 | 23.163 | 3.392 |
| Gross Profit/Loss - EUR | - | 6.531 | 5.420 | 12.172 | 19.734 | 26.202 | 13.376 | -6.074 | 23.016 | 19.593 |
| Net Profit/Loss - EUR | - | 6.292 | 4.668 | 11.641 | 18.921 | 24.990 | 12.502 | -6.290 | 19.233 | 16.405 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Cytologica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 7.942 | 5.814 | 4.139 | 127 | 40.578 | 32.347 | 24.444 | 0 | 0 |
| Current Assets | - | 5.108 | 4.773 | 16.672 | 19.187 | 7.153 | 546 | 1.306 | 31.797 | 19.421 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 28 | 4 | 257 | 1.059 | 546 | 547 | 27.853 | 16.575 |
| Cash | - | 5.108 | 4.745 | 16.668 | 18.930 | 6.094 | 0 | 759 | 3.944 | 2.846 |
| Shareholders Funds | - | 6.337 | 4.711 | 16.266 | 18.971 | 25.039 | 12.480 | 6.229 | 25.443 | 16.453 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 6.713 | 5.876 | 4.545 | 343 | 21.465 | 20.412 | 19.521 | 6.354 | 2.968 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 1.227 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8691 - 8691" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Cytologica Srl